Get the Stockscreener App
72.29
0.54%
-0.39
After Hours:
72.04
-0.25
-0.35%
Henry Schein Inc stock is traded at $72.29, with a volume of 1.31M.
It is down -0.54% in the last 24 hours and down -9.15% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
See More
Previous Close:
$72.68
Open:
$72.24
24h Volume:
1.31M
Relative Volume:
0.97
Market Cap:
$8.29B
Revenue:
$13.18B
Net Income/Loss:
$419.00M
P/E Ratio:
22.10
EPS:
3.2704
Net Cash Flow:
$521.00M
1W Performance:
-4.34%
1M Performance:
-9.15%
6M Performance:
+6.53%
1Y Performance:
+2.61%
1-Day Range:
$71.73
$73.36
1-Week Range:
$71.24
$76.45
52-Week Range:
$60.56
$89.29
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
72.29 | 8.34B | 13.18B | 419.00M | 521.00M | 3.2704 |
MCK
Mckesson Corporation
|
885.84 | 110.11B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
326.91 | 64.53B | 325.78B | 1.64B | 3.61B | 8.3139 |
CAH
Cardinal Health Inc
|
207.83 | 49.63B | 244.67B | 1.68B | 5.51B | 6.9487 |
AHG
Akso Health Group Adr
|
2.36 | 2.07B | 14.85M | -136.07M | 7.23M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-23-26 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Top Henry Schein Executive Makes Notable Insider Stock Move - TipRanks
Henry Schein (NASDAQ:HSIC) CEO Thomas Popeck Sells 1,355 Shares - MarketBeat
Insider Sell: Thomas Popeck Sells Shares of Henry Schein Inc (HS - GuruFocus
Charisma 66000085 Universal CompositeHenry Schein Dental - hotelier.com.py
Henry Schein CEO Popeck sells $98,630 in stock - Investing.com
Henry Schein (HSIC) products CEO sells 1,355 shares in open-market trade - Stock Titan
This Henry Schein analyst turns bullish; here are top 3 upgrades for Monday - MSN
Henry Schein, Vir Biotechnology, Ultra Clean Holdings and other big stocks moving higher on Tuesday - MSN
3M Scotchbond 7423 Etchant Etching GelHenry Schein Dental - hotelier.com.py
Here's why Henry Schein (HSIC) is a strong growth stock - MSN
HSIC (NASDAQ) Form 144: insiders list 144, 191, 1,020 shares tied to vesting - Stock Titan
Zacks Research Has Negative View of Henry Schein Q1 Earnings - MarketBeat
Henry Schein Inc. stock outperforms competitors on strong trading day - MSN
Henry Schein Q4 2025 earnings preview - MSN
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Henry Schein secures Ethisphere World Most Ethical Companies recognition for 15th consecutive year - Traders Union
Henry Schein Named Among World’s Most Ethical Companies - Dentistry Today
Here's Why Henry Schein (HSIC) is a Strong Growth Stock - Yahoo Finance
These analysts increase their forecasts on Henry Schein after upbeat Q4 results - MSN
NY-HENRY-SCHEIN-INC - Caledonian Record
Ethisphere Names Henry Schein as One of the 2026 World's Most Ethical Companies® for 15th Consecutive Year - Bluefield Daily Telegraph
HS2.DE Henry Schein (XETRA) €74.06 pre-market 18 Mar 2026: oversold bounce setup vs 50-day avg - Meyka
Henry Schein (NASDAQ: HSIC) CFO surrenders shares to cover tax withholding - Stock Titan
Henry Schein (HSIC) SVP surrenders 463 shares to cover tax withholding - Stock Titan
Henry Schein (HSIC) executive surrenders 587 shares to cover tax withholding - Stock Titan
Henry Schein (HSIC) EVP surrenders 5,928 shares to cover tax withholding - Stock Titan
[Form 4] HENRY SCHEIN INC Insider Trading Activity - Stock Titan
Henry Schein (HSIC) director logs share gift and tax-related surrender - Stock Titan
Henry Schein (HSIC) exec surrenders 1,401 shares for tax withholding - Stock Titan
Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Down 12.8% in February - MarketBeat
Reflecting On Dental Equipment & Technology Stocks’ Q4 Earnings: Henry Schein (NASDAQ:HSIC) - Yahoo Finance
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein (HSIC) director Bergman reports bona fide gift of 970 shares - Stock Titan
Kettle Hill Capital Management LLC Acquires New Holdings in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein, Inc. $HSIC is Clifford Capital Partners LLC's 2nd Largest Position - MarketBeat
Henry Schein, Inc. $HSIC is Ananym Capital Management LP's 3rd Largest Position - MarketBeat
Zuckerman Investment Group LLC Acquires 72,040 Shares of Henry Schein, Inc. $HSIC - MarketBeat
iSAM Funds UK Ltd Acquires New Stake in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein, Inc. $HSIC Shares Sold by P2 Capital Partners LLC - MarketBeat
Henry Schein (NASDAQ:HSIC) Cut to "Buy" at Wall Street Zen - MarketBeat
HSIC SEC FilingsHenry Schein, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Henry Schein, Inc. $HSIC Shares Sold by Wolf Hill Capital Management LP - MarketBeat
How Henry Schein (HSIC) Story Is Shifting As Analysts Reset Fair Value Targets - Yahoo Finance
HSIC Stock Price, Quote & Chart | HENRY SCHEIN INC (NASDAQ:HSIC) - ChartMill
Henry Schein Inc. stock outperforms competitors despite losses on the day - MarketWatch
Henry Schein: Still A BuyBut Caution Is Warranted (NASDAQ:HSIC) - Seeking Alpha
Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Rating of "Hold" from Analysts - MarketBeat
Insider Sell: Kurt Kuehn Sells Shares of Henry Schein Inc (HSIC) - GuruFocus
Insider Selling: Henry Schein (NASDAQ:HSIC) Director Sells 2,844 Shares of Stock - MarketBeat
Henry Schein (HSIC) director Kurt Kuehn sells 2,844 shares in open market - Stock Titan
Healthcare Briefs: Henry Schein Cuts Ribbon on New Dallas Discovery Center - D Magazine
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.48%
3.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):